<?xml version="1.0" encoding="UTF-8"?>
<ref id="ref89">
 <mixed-citation publication-type="journal" id="cit89">
  <name>
   <surname>Channappanavar</surname>
   <given-names>R.</given-names>
  </name>; 
  <name>
   <surname>Lu</surname>
   <given-names>L.</given-names>
  </name>; 
  <name>
   <surname>Xia</surname>
   <given-names>S.</given-names>
  </name>; 
  <name>
   <surname>Du</surname>
   <given-names>L.</given-names>
  </name>; 
  <name>
   <surname>Meyerholz</surname>
   <given-names>D. K.</given-names>
  </name>; 
  <name>
   <surname>Perlman</surname>
   <given-names>S.</given-names>
  </name>; 
  <name>
   <surname>Jiang</surname>
   <given-names>S.</given-names>
  </name>
  <article-title>Protective effect of intranasal regimens containing peptidic middle east respiratory syndrome coronavirus fusion inhibitor against mers-cov infection</article-title>. 
  <source>J. Infect. Dis.</source>
  <year>2015</year>, 
  <volume>212</volume>, 
  <fpage>1894</fpage>â€“
  <lpage>1903</lpage>. 
  <pub-id pub-id-type="doi">10.1093/infdis/jiv325</pub-id>.
  <pub-id pub-id-type="pmid">26164863</pub-id>
 </mixed-citation>
</ref>
